09:53 AM EST - Theralase® Technologies Inc. : Has been granted a U.S. Patent for Multiwavelength PhotoDynamic Therapy technology. The U.S. patent entitled "Apparatus and Method for Multiwavelength Photodynamic Therapy" allows Theralase to use various laser wavelengths in the activation of PhotoDynamic Compounds in cancerous tumours. The advantage is that a large or deep seated tumour may be only partially destroyed with laser of a particular wavelength, but then fully destroyed by employing one or two additional laser wavelengths, as different laser wavelengths are able to penetrate to different tissue depths. This would be especially important for cancers, such as Glio Blastoma Multiforme or Non-Small Cell Lung Cancer Theralase® Technologies Inc.
shares V.TLT are trading unchanged at $0.31.
